
Bayer (Germany)
Bayer (Germany)
34 Projects, page 1 of 7
assignment_turned_in Project2016 - 2018Partners:Bayer (Germany), Bayer AG, University of EdinburghBayer (Germany),Bayer AG,University of EdinburghFunder: UK Research and Innovation Project Code: BB/N002458/1Funder Contribution: 472,277 GBPBACKGROUND AND PURPOSE We recently discovered a unique enzyme (HTG or hetero-trans-b-glucanase), found only in a group of non-flowering plants, the horsetails. Flowering plants lack HTG even though their cell walls contain the chain-like molecules which, at least in the test-tube, HTG can cut and re-join. We now aim to discover (a) what good HTG does horsetail plants, (b) the full range of 'cutting and re-joining' reactions that HTG can achieve, (c) what happens when HTG from horsetails is artificially transferred to crop plants. We predict that the horsetail enzyme will endow flowering crops, e.g. wheat, with the ability to strengthen their stems in a manner hitherto only available to horsetails. Such crops may acquire improved resistance to lodging (storm damage). OBJECTIVES AND EXPECTED OUTCOMES Remarkably, horsetail HTG is the only known enzyme from any living thing that can 'cut and re-join' molecules of cellulose, the major constituent of plant cell walls. It can graft a cellulose chain onto a chain of a different cell-wall building material called xyloglucan. HTG can also graft chains of a third such material (MLG or mixed-linkage glucan) onto xyloglucan. HTG can thus create cellulose-to-xyloglucan and MLG-to-xyloglucan linkages. The resulting 'hybrid' polymers are thought to strengthen horsetails. We will discover exactly when and where HTG is produced, and such linkages are formed, in horsetails. This will potentially give clues about HTG's natural roles. We will also discover what new reactions HTG can catalyse when mixed in the test-tube with diverse plant cell-wall polysaccharides. This may afford new 'hybrid' polymers, which when scaled up may be commercially valuable new materials. To further our fundamental knowledge of HTG, we will also investigate which of the enzyme's amino acids are important for its ability (in the test-tube) to re-configure cellulose and MLG. A major part of this project involves artificially introducing the horsetail's HTG activities into flowering plants, including both dicotyledons and cereals, and measuring the consequences. Our industrial collaborators (Bayer CropScience) will do this work in the case of wheat. We predict that any crop plants genetically transformed in this way will be able to create cellulose-to-xyloglucan linkages in their cell walls, and that cereals (which, unlike dicots, possess MLG as well as cellulose and xyloglucan) will in addition be able to make MLG-to-xyloglucan linkages. We will test these predictions experimentally. We will also test whether the HTG-endowed flowering plants are stronger, and whether they have an altered shape or size. We will quantify the plants' mechanical strength by measuring the force required to bend or break their stems. Any changes to the molecular architecture a plant's cell walls are likely to affect its growth and strength because of the pivotal roles that cell walls play in dictating these features. BENEFICIARIES OF THE PROJECT Cereal varieties with stronger stems often suffer less lodging, but such strengthening is usually achieved by the plant growing thicker stems at the expense of lower grain yield. Artificially giving cereals HTG may form novel inter-polymer linkages in the cell wall and confer similar strengthening without significant increases in stem biomass and thus without compromising the harvest. Modifying cereals in this way would benefit plant breeders and farmers, as well as the general public, by improving the reliability of grain production in a changing climate as storms and heavy rains become more frequent. In addition, increasing knowledge of HTG's ability to reconfigure biomass materials, especially cellulose (the world's most abundant organic substance), offers biotechnologists novel opportunities to create new materials (e.g. for specialist papers and medical applications) via non-polluting 'green' processes.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::42a5d07ea16ebc7dc80fdbf315f7b1a0&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::42a5d07ea16ebc7dc80fdbf315f7b1a0&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.euassignment_turned_in Project2024 - 2026Partners:Bayer (Germany), University of Warwick, RWTHBayer (Germany),University of Warwick,RWTHFunder: UK Research and Innovation Project Code: EP/Y003527/1Funder Contribution: 137,661 GBPThis project will combine large-scale electronic patient data, artificial intelligence algorithms, and mechanistic mathematical models, to develop systems that can improve the diagnosis, and hence treatment, of critically ill patients with acute respiratory distress syndrome (ARDS). The key idea is to use mechanistic virtual patient models as "filters" to extract relevant medical information on individual patients, significantly reducing biases introduced by machine learning on heterogeneous datasets, and allowing improved discovery of patient cohorts driven exclusively by medical conditions. I propose to establish a collaboration with Prof Andreas Schuppert at Aachen University and Dr Jörg Lippert at Bayer Healthcare in Germany that will give me access to large-scale patient data and internationally leading expertise in applying machine learning to real clinical problems. As noted recently by leading medical researchers in the journal Intensive Care Medicine, "Artificial Intelligence approaches such as machine learning may assist in identification of patients at risk of or fulfilling diagnostic criteria for ARDS, although this technology is not yet ready for clinical implementation". In ARDS, patient outcomes are poor, while hospital costs are huge - this collaboration will make breakthroughs in the clinical applicability of digital technologies for the earlier identification of ARDS, improving treatment of patients and reducing costs to healthcare providers.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::a5bc5c38b4ce86267d02e94887bbd95c&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::a5bc5c38b4ce86267d02e94887bbd95c&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.euassignment_turned_in Project2014 - 2018Partners:University of Aberdeen, Bayer AG, Bayer (Germany)University of Aberdeen,Bayer AG,Bayer (Germany)Funder: UK Research and Innovation Project Code: BB/M503228/1Funder Contribution: 94,126 GBPDoctoral Training Partnerships: a range of postgraduate training is funded by the Research Councils. For information on current funding routes, see the common terminology at https://www.ukri.org/apply-for-funding/how-we-fund-studentships/. Training grants may be to one organisation or to a consortia of research organisations. This portal will show the lead organisation only.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::7a6c8ddd69a61e78c5ad382bbab9c9b2&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::7a6c8ddd69a61e78c5ad382bbab9c9b2&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.euassignment_turned_in Project2014 - 2019Partners:Bayer (Germany), University of Edinburgh, Bayer AGBayer (Germany),University of Edinburgh,Bayer AGFunder: UK Research and Innovation Project Code: BB/M503216/1Funder Contribution: 94,126 GBPDoctoral Training Partnerships: a range of postgraduate training is funded by the Research Councils. For information on current funding routes, see the common terminology at https://www.ukri.org/apply-for-funding/how-we-fund-studentships/. Training grants may be to one organisation or to a consortia of research organisations. This portal will show the lead organisation only.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::fccb819a171d29bfa43afb11763ae826&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::fccb819a171d29bfa43afb11763ae826&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.euassignment_turned_in Project2020 - 2024Partners:Bayer AG, University of Bristol, University of Bristol, Bayer (Germany)Bayer AG,University of Bristol,University of Bristol,Bayer (Germany)Funder: UK Research and Innovation Project Code: EP/T031077/1Funder Contribution: 527,368 GBPThe response of a material to mechanical loading is one of its most basic properties. Under sufficient load, materials yield and fail, often in a catastrophic fashion. This macroscopic behaviour is ultimately governed by the particles that make up the material - for example, its constituent atoms and molecules. In many applications, one would like to predict a material's macroscopic behaviour, starting from its microscopic constituents. We propose to study the links between microscopic and macroscopic properties of a class of soft materials. These materials are assembled using microscopic particles much bigger than atoms, and interact more weakly. Thus the cohesive forces that hold the particles together are much weaker: the materials are soft and can be easily deformed by mechanical loads. Moreover, in contrast to many familiar materials, the arrangement of the particles is amorphous, and does not resemble the ordered crystals that one typically finds in metals or minerals. This class of material includes gels, as used in products like pesticides, cosmetics, or food. After being prepared, gels degrade with time and eventually become so unstable that they collapse under their own weight. This limits the shelf-life of many products - by analysing the degradation process and linking it to the microscopic behaviour, we hope to inform the design and formulation of future products. Our proposed research will focus on gels formed from emulsions, which consist of microscopic droplets of oil suspended in a watery medium. Milk is an example of such an emulsion. However, the emulsion that we will use has been tailored to allow new kinds of measurement: our emulsion droplets include special fluorescent dye molecules which respond to a mechanical load. We use an extremely powerful microscope (sometimes called a "nanoscope") to see dye molecules at the contact point between two adjacent oil droplets. The more the droplets are squeezed, the brighter the light from the dye molecules. Depending on the experimental conditions, we can assemble these droplets into a network (a gel) or pack them until they almost touch to form a "glass". We will study these amorphous solids, under mechanical load. Together with the dye, our nanoscope will allow us to measure the forces between these microscopic droplets. This kind of measurement has not been possible until now, and will give us vital new information as we analyse the links between the particles' behaviour and the macroscopic properties of the gel. Our experiments will be compared with computer simulations, which provide accurate microscopic descriptions of these materials, without the difficulties associated with imaging small droplets. But there are restrictions on the system sizes and time scales such microscopic simulations access, due to limited computational resources. We will combine simulation and experiment, which provide complementary information - the simulations are accurate on small scales while the experiments reveal the behaviour of macroscopic systems. The experiments will be tested and calibrated against the simulation data. In this way, we answer two kinds of question. First, we understand what happens as a material yields, either under its own weight (gels) or as it flows in response to an external force (glasses). For example, where are the weak points where these materials fail? Can this process be controlled? Second, we will compare our results with theoretical predictions to understand the principles that govern the properties of these materials. Different theories make different assumptions, and make a range of predictions about how amorphous solids yield and flow, and how this depends on their microscopic structure. Our experimental measurement of forces will provide detailed information about these colloidal systems, allowing us to test the theoretical predictions in new ways, and - we hope - to uncover new physical behaviour.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::a64b9152531128921901a27a66d9aa79&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::a64b9152531128921901a27a66d9aa79&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eu
chevron_left - 1
- 2
- 3
- 4
- 5
chevron_right